Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-16, Stock:JNJ, The news for the past five days is as follows:
2019-07-09: NEWS1: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS2: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS3: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS4: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS5: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS6: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS7: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS8: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS9: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS10: Judge rules against Trump on drug pricing disclosures.NEWS11: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS12: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS13: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS14: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS15: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS16: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS19: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS20: With new execs on board, Celsius signs Janssen deal.NEWS21: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS22: J&J and Microsoft Among Defensive Stocks With Positive Earnings Outlooks.
2019-07-10: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Johnson & Johnson Wins New Trial In Talc Case.NEWS3: Is Shopify Stock Getting Ahead of Its Fundamentals?.NEWS4: The 10 Biggest Healthcare Stocks.NEWS5: Dow Movers: HD, AXP.NEWS6: Dow Movers: HD, AXP.NEWS7: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Late Surge Helps S&P Join NASDAQ in the Green.NEWS10: Johnson & Johnson submits Jacksonville expansion plans.NEWS11: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS12: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.
2019-07-11: NEWS1: These ETFs make investing easy — even if you’re broke.NEWS2: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS3: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS4: Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer.NEWS5: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS6: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS7: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS8: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS11: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS12: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS13: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS14: UPDATE 1-Eli Lilly's bio-medicines head to leave next month.NEWS15: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS16: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS17: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.
2019-07-12: NEWS1: Here's Why Johnson & Johnson Dropped 4% Today.NEWS2: Here's Why Johnson & Johnson Dropped 4% Today.NEWS3: Dow, S&P, Nasdaq Close the Week at New Highs.NEWS4: Dow, S&P, Nasdaq Close the Week at New Highs.NEWS5: Here&apos;s Why Johnson & Johnson Dropped 4% Today.NEWS6: Johnson & Johnson Breaks Below 200-Day Moving Average - Notable for JNJ.NEWS7: Johnson & Johnson Breaks Below 200-Day Moving Average - Notable for JNJ.NEWS8: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 8,244.15..NEWS9: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 8,244.15..NEWS10: Dow Jones Today: A Fantastic Friday.NEWS11: J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders.NEWS12: US STOCKS-Wall St notches all-time highs on lingering rate-cut optimism.NEWS13: 4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB.NEWS14: J&J Denials of Asbestos in Baby Powder Spur Criminal Probe.NEWS15: Friday Sector Laggards: Healthcare, Utilities.NEWS16: Friday Sector Laggards: Healthcare, Utilities.NEWS17: 4 Healthcare Stocks That Are Feeling Sick.NEWS18: Johnson & Johnson tumbles amid reports of criminal investigation.NEWS19: J&J Draws U.S. DOJ Probe on Talcum Powder Asbestos Denials.NEWS20: Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation.NEWS21: Notable Friday Option Activity: JNJ, NLSN, CAT.NEWS22: Notable Friday Option Activity: JNJ, NLSN, CAT.NEWS23: Johnson & Johnson Falls On Report Of Justice Department Probe.NEWS24: US STOCKS-Wall Street hits new highs on rate-cut optimism.NEWS25: J&J faces U.S. criminal probe related to baby powder - Bloomberg.NEWS26: J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders.NEWS27: Johnson & Johnson stock dives 4.3% after Bloomberg reports that DOJ is pursuing criminal investigation into company.NEWS28: Johnson & Johnson Stock Drops on Baby Powder Report.NEWS29: J&J Stock Dives As DOJ Reportedly Seeks Criminal Probe Into Talc Powders.NEWS30: J&J faces U.S. criminal probe related to baby powder - Bloomberg.NEWS31: Johnson & Johnson faces criminal probe related to baby powder: Bloomberg.NEWS32: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS33: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS34: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS35: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS36: Johnson & Johnson to test experimental HIV vaccine in U.S., Europe.NEWS37: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS38: Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug.NEWS39: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS40: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS41: Bull of the Day: Penumbra (PEN).NEWS42: Bull of the Day: Penumbra (PEN).NEWS43: J&J Stock Sinks as Feds Probe Baby Powder Cancer Allegations.NEWS44: Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership.NEWS45: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS46: Congo rules out using additional trial vaccines to combat Ebola.NEWS47: Here’s how many points a U.S.-China trade deal is worth to the S&P 500, according to J.P. Morgan’s top strategist.NEWS48: Bull of the Day: Penumbra (PEN).NEWS49: Drugmakers braced for opioid crisis reckoning.
2019-07-15: NEWS1: Stocks End Choppy Session at New Highs.NEWS2: Stocks End Choppy Session at New Highs.NEWS3: J&J Submits BLA for Subcutaneous Formulation of Darzalex.NEWS4: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS5: Pre-Market Earnings Report for July 16, 2019 :  JPM, JNJ, WFC, GS, PLD, CP, FRC, DPZ, CBSH, SNV, FHN, MBWM.NEWS6: Pre-Market Earnings Report for July 16, 2019 :  JPM, JNJ, WFC, GS, PLD, CP, FRC, DPZ, CBSH, SNV, FHN, MBWM.NEWS7: Daily Dividend Report: JNJ, VMC, AGCO, GT, CBT.NEWS8: Daily Dividend Report: JNJ, VMC, AGCO, GT, CBT.NEWS9: Citigroup, Johnson & Johnson, IBM, and More Stocks to Watch This Week.NEWS10: Johnson & Johnson Q2 Earnings Outlook.NEWS11: These Stocks Are Unlike The Others; Can You Profit From Them?.NEWS12: Tracking XLV ETF And SPDR ETFs: These Stocks Are Unlike The Others; Can You Profit From Them?.NEWS13: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS14: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS15: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS16: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS17: UPDATE 4-Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end.NEWS18: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS19: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS20: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS21: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS22: Bull Signal Sounds for Johnson & Johnson Stock Before Earnings.NEWS23: Company News for Jul 15, 2019.NEWS24: Company News for Jul 15, 2019.NEWS25: Dow Movers: GS, MRK.NEWS26: Dow Movers: GS, MRK.NEWS27: Johnson & Johnson (JNJ) 2nd Quarter Earnings: What to Expect.NEWS28: Johnson & Johnson (JNJ) 2nd Quarter Earnings: What to Expect.NEWS29: Dow ETF Appears Strong Ahead of Q2 Earnings.NEWS30: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS31: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS32: CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic.NEWS33: Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2019.NEWS34: Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season.NEWS35: Earnings Season Starts With Beat From Citigroup; Other Banks, Netflix Report Later In Week.NEWS36: Here’s What’s Overshadowing JNJ’s HIV Vaccine Progress.NEWS37: Company News for Jul 15, 2019.NEWS38: Monday’s Vital Data: Johnson & Johnson, Ford and Square.NEWS39: Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results.NEWS40: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS41: J&J Reports Earnings Under a Cloud of Baby Powder.NEWS42: Earnings Watch: Expect drama in second-quarter numbers as trade fears weigh.NEWS43: J&J earnings preview: Wall Street is still optimistic despite company’s legal issues.NEWS44: Opioid 'kingpin' J&J fuelled epidemic, Oklahoma argues at trial's end.NEWS45: Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end.NEWS46: Johnson & Johnson Is Reporting Its Earnings on Tuesday. Here’s What To Expect..

Answer: Decrease